Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
赞助:
University of Miami
合作者:
信息的提供 (责任方):
Nelson Claure,University of Miami
| 追踪信息 | |||
|---|---|---|---|
| 首次提交日期 ICMJE | October 2, 2018 | ||
| 首次发布日期e ICMJE | October 4, 2018 | ||
| 最后更新发布日期 | October 4, 2018 | ||
| 预计研究开始日期 ICMJE | October 31, 2018 | ||
| 预计主要完成日期 | October 31, 2019 (主要结果测量的最终数据收集日期) | ||
| 目前主要观察指标 ICMJE |
ventilatory stability by frequency of central apnea[ Time Frame: 2 hours ] ventilatory stability by frequency of obstructive apnea[ Time Frame: 2 hours ] ventilatory stability by density of periodic breathing[ Time Frame: 2 hours ] ventilatory stability by time series of inter-breath intervals[ Time Frame: 2 hours ] |
||
| 原始主要观察测量 ICMJE | 与当前相同 | ||
| 目前的二级观察 ICMJE |
|
||
| 描述性信息 | |||
| 简略标题 ICMJE | Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants | ||
| 正式标题 ICMJE | Impact of Arterial Oxygen Saturation Range on Ventilatory Stability in Extremely Premature Infants | ||
| 简要概况 | This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2), both within the clinically recommended range of 90- 95%. The specific objective of this study to evaluate the impact of targeting SpO2 within 93-95% compared to the 90-92% range on ventilatory stability in premature infants of 23-29 weeks gestational age (GA). |
||
| 详细说明 | |||
| 研究类型 ICMJE | Interventional | ||
| 研究阶段 | N/A | ||
| 研究设计 ICMJE | 分配: Randomized 干预模型: Crossover Assignment 干预模型描述: This is a prospective crossover study to compare the within-subject effect of the two target ranges of arterial oxygen saturation (SpO2, 93-95% vs 90-92%) on ventilatory stability in premature infants. 盲法: Interventional 盲法描述: 主要目的: Other |
||
| 适用条件 ICMJE | |||
| 干预项目 ICMJE |
|
||
| 研究工具 |
|
||
| 招募信息 | |||
| 招募状态 ICMJE | Not yet recruiting | ||
| 预计入组 ICMJE |
24 | ||
| 原始预计入组 ICMJE | 与当前相同 | ||
| 预计研究完成日期 | October 31, 2019 | ||
| 预计主要完成日期 | October 31, 2019 (主要结果测量的最终数据收集日期) | ||
| 合格标准 ICMJE | Inclusion Criteria: - 23 0/7- 29 6/7 weeks gestational age - Postnatal age ≥ 14 days - Requiring FiO2 ≥ 0.25 to keep SpO2 90-95% - Parental informed consent Exclusion Criteria: - Severe congenital anomalies that may affect pulmonary or neurosensory development - Severe CNS pathology that may alter respiratory control function | ||
| 性别 |
|
||
| 年龄 | 最小年龄:N/A ,最大年龄:18 Weeks | ||
| 接受健康的志愿者 | 没有 | ||
| 可入组国家 ICMJE | United States | ||
| 管理信息 | 数据检测委员会 | No | |
| 研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
| IPD 共享声明 |
|
||
| 责任方 | Nelson Claure,University of Miami | ||
| 研究赞助商 ICMJE | University of Miami | ||
| 合作者 ICMJE | |||
| 研究员 ICMJE |
|
||
| PRS 账户 | University of Miami | ||
| 验证日期 | October 2018 | ||
|
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
|||
请使用微信扫码报名

